Option Care Health (NASDAQ:OPCH – Get Free Report) is expected to issue its quarterly earnings data before the market opens on Wednesday, February 26th. Analysts expect the company to announce earnings of $0.33 per share and revenue of $1.29 billion for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link.
Option Care Health Trading Down 1.2 %
Shares of NASDAQ OPCH opened at $32.00 on Monday. The stock’s 50 day moving average price is $27.71 and its two-hundred day moving average price is $27.97. Option Care Health has a 52-week low of $21.39 and a 52-week high of $34.63. The stock has a market capitalization of $5.45 billion, a P/E ratio of 26.89, a PEG ratio of 2.30 and a beta of 1.35. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77.
Analyst Upgrades and Downgrades
Several analysts recently commented on the company. UBS Group assumed coverage on Option Care Health in a research report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 target price on the stock. JPMorgan Chase & Co. raised their price objective on Option Care Health from $38.00 to $40.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and raised their target price for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. Truist Financial cut their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a report on Friday, November 1st. Finally, The Goldman Sachs Group lowered Option Care Health from a “buy” rating to a “neutral” rating and cut their target price for the company from $38.00 to $27.00 in a report on Monday, November 4th. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, Option Care Health currently has an average rating of “Moderate Buy” and an average price target of $32.25.
About Option Care Health
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Articles
- Five stocks we like better than Option Care Health
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- How Technical Indicators Can Help You Find Oversold StocksĀ
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.